Latest Market News

Dubber Corporation Limited will record a significant non-cash impairment charge in FY25 following the loss of a major customer contract with Virgin Media O2, impacting its intangible assets from a prior acquisition.

Eneco Refresh Limited has reversed its fortunes with a modest profit in FY25, driven by steady revenue growth and operational improvements across key regions and business units.

MA Credit Income Trust has reported a $9.7 million profit and successfully raised $49.7 million through a wholesale placement, delivering a net return of 2.95% since its ASX listing in March 2025.

DataDot Technology Limited reported a 13% revenue increase and a 56% rise in net profit after tax for FY25, driven by growth in its PropertyVAULT insurance services and new distributor partnerships.

Kinatico Limited has reported a robust 12% increase in revenue and a striking 45% rise in profit after tax for the financial year ended June 2025, underscoring solid operational momentum despite no dividend payouts.

Cleo Diagnostics reported a $4 million loss for FY2025 while making significant strides toward FDA approval of its novel ovarian cancer blood test. The company is progressing clinical trials and scaling manufacturing in preparation for market entry.

Race Oncology Limited reported a significantly reduced loss for FY2025, driven by key clinical trial progress and strategic leadership changes. The company advances its RC220 program with promising Phase 1 dosing milestones and strengthens its governance to support future growth.

CVC Limited reports a stable FY2025 profit alongside a robust landbank poised for significant value uplift, targeting a net tangible asset per share of $5.75 through strategic rezoning and development.

CVC Limited has reversed its fortunes with a $0.5 million net profit after tax for FY25, driven by strong property investment income and strategic land developments, while maintaining a cautious capital management approach and withholding dividends.

Ironbark Capital Limited reported a 17.6% increase in net profit for FY2025, driven by higher investment income and realised gains, alongside a raised fully franked dividend and an extended share buy-back program.

Eildon Capital Group reported a $5.7 million net loss in FY25, weighed down by $8 million in one-off charges, while simplifying its portfolio and entering a new joint venture in North Queensland.

Eildon Capital Group reported a net loss of $5.7 million for FY2025, weighed down by significant one-off impairments, while pivoting to focused real estate investments with a new $20.8 million joint venture in Queensland.